1 minute reading time (54 words)

New Therapy Reduces Chronic Low Back Pain in Large International Study

AAPM member John Markman, MD is the lead author of a new study that has found tanezumab, a monoclonal antibody that inhibits nerve activity, provides relief in patients with chronic low back pain, one of the leading reasons why people seek medical care and the number one cause of disability worldwide. Full story

Related Posts

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More